Inpatient Discharge Summary
Emily Turner, MRN# 784512369, is a 63 y.o. female, admitted to the Cardiology service due to acute myocardial infarction. Admission Date: 2/15/2023 Discharge Date: 2/25/2023 Attending Provider: Dr. Aaron Schmidt
Treatment Team:
First Contact: CARDIOLOGY TEAM - PAGER 63524
Nursing Contact: Nancy Clarke, RN
Hospital Problems Noted - Resolved
POA Active Problems:
1. Acute myocardial infarction 2/15/2023 - Present: Yes
2. Hypertension 2/15/2023 - Present: Yes
3. Type 2 Diabetes Mellitus 2/15/2023 - Present: Yes
Resolved Problems:
RESOLVED: Congestive Heart Failure 2/16/2023 - 2/24/2023: Yes
Recommendations for Follow Up:
Attention to Primary Care Provider: 
General follow up with cardiac function assessment. 
To Do's for Referring / Subspecialty Provider(s):
Cardiology: Follow-up appointment on 3/1/2023.
Endocrinology: Follow up scheduled for 3/15/2023.
Lab, Diagnostic Testing, and Referral Follow-Up Orders given to patient:
Contact information for follow-up with Dr. Sara Lewiston, Midtown Heart Clinic, 312-555-0198.
Next Steps:
Follow up with Heartwise Patient Care 554-123-8576
Instructions: Emily will receive supports at home by health aides from HomeCare Professionals. Scheduled Appointments:
Future Appointments:
Date Time Provider Department Center 
3/1/2023 10:30 AM Evelyn White, NP Card Clinic HCC
3/15/2023 9:00 AM Ira Schwarz, MD Endo Clinic EC
3/15/2023 11:00 AM Donna Pierce, RN Diabetes Management Diab Mgmt.
Pertinent Clinical Presentation on Admission/Reason for Hospitalization:
63-year-old female presented with severe chest pain and shortness of breath on 2/15/2023. Noted history of hypertension and poorly controlled diabetes. EKG confirmed acute myocardial infarction. She was immediately started on IV thrombolytics and admitted for further management.
Brief Hospital Course (including treatment rendered and response to treatment):
Ms. Turner was stabilized and transferred to the intensive care unit for continuous monitoring and further treatment. Her hospital course included optimization of her diabetic care and adjustment of her hypertension medications. She responded well to the treatments and was gradually transitioned to oral medications.
Discharge Medication List:
New Medications:
- Aspirin 81 mg, Oral, ONCE DAILY
- Metformin 500 mg, Oral, TWICE DAILY
- Lisinopril 10 mg, Oral, ONCE DAILY
Total Score (Last filed: 2/25/2023 1500) 4 Length of Stay 6 Acute Admission 7 Charleson Comorbidity Score Criteria that do not apply: ED Visits in last 6 months LACE is a risk assessment tool used to identify patients at risk for unplanned Readmission or Death within 30 days of discharge. Variables contributing to the score are Length of stay, Acuity of admission (emergent vs. non-emergent), Comorbidities (type & number of coexisting medical conditions), and number of Emergency department visits in the last 6 months. LACE Score Risk Level Readmission Rate - 30 Day Mortality Rate - 30 Day 1-4 Low 3.3% 0.1% 5-9 Moderate 7.9% 0.7% 10-12 High 14.7% 2.5% 13-19 Highest 20.8% 5.8% Last Recorded Vital Signs: BP 128/82 | Pulse 72 | Temp 36.8 °C | Resp 16 | SpO2 98% | Weight 72 kg | BMI 27.5 kg/m²
Discharge Exam:
Physical Exam Findings:
- General: Awake, alert, no acute distress
- Cardiovascular: Regular rate and rhythm, no murmurs
- Respiratory: Clear to auscultation
- Extremities: No edema
- Neurologic: Alert and oriented, no focal deficits
The patient expressed understanding of discharge instructions and follow-up plans. She was advised to monitor her blood pressure and blood sugar levels regularly. The discharge process was completed with the patient in stable condition.